Diethylpropion HCl Controlled-Release

Product NDC: 50090-0121
11-digit product format: 500900121
Labeler code: 50090
Product ID: 50090-0121_598fae94-e114-4fb6-8c36-5e6627b86baf
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Diethylpropion hydrochloride
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: NDA012546
Marketing category: NDA
Marketing start: 1960-11-17
Marketing end: 0000-00-00
Substance: DIETHYLPROPION HYDROCHLORIDE
Active strength: 75 mg/1
Pharmacologic classes: Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50090-0121		I	Inactivated by FDA	2026-08-11
excluded package	package	50090-0121	50090-0121-0	I	Inactivated by FDA	2026-08-11
excluded package	package	50090-0121	50090-0121-1	D	Discontinued by firm	2026-08-11
excluded package	package	50090-0121	50090-0121-4	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0121-0	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0121-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0121-4	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0121-0	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0121-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0121-4	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0121-0	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0121-1	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0121-4	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0121-0	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0121-1	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0121-4	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0121-0	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0121-1	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0121-4	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0121-0	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0121-1	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0121-4	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0121-0	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0121-1	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0121-4	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0121-0	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0121-1	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0121-4	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0121-0	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0121-1	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0121-4	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0121-0	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0121-1	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0121-4	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0121-0	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0121-1	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0121-4	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0121-0	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0121-1	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0121-4	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-0121-0	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-0121-0	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-0121-0	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	50090-0121-0	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	50090-0121-0	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	50090-0121-0	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N012546-001	TENUATE DOSPAN	DIETHYLPROPION HYDROCHLORIDE	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL	AB	RLD, RS, Approved before 1982	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N012546-001	TENUATE DOSPAN	75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N012546-001	TENUATE DOSPAN	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, Approved before 1982	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-07-19 19:46 UTC	2019-07	N012546-001	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
0029c986-f448-4e26-865d-441bd9700d12	Product name	1	20201013
a29cb53e-8fe0-4754-9013-e084b50c1c66	Product name	1	20170614

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-0121-0	2020-01-31	C162847	48780-1	9d75b9d0-641e-f424-e053-dadaa90a57ce	70025263 Diethylpropion HCl USP C-IV Immediate-Release 25 mg Tablets Diethylpropion HCl USP C-IV Controlled-Release 75 mg Tablets Rx only Rev. March 2014
50090-0121-1	2020-01-31	C162847	48780-1	9d75b9d0-641e-f424-e053-dadaa90a57ce	70025263 Diethylpropion HCl USP C-IV Immediate-Release 25 mg Tablets Diethylpropion HCl USP C-IV Controlled-Release 75 mg Tablets Rx only Rev. March 2014
50090-0121-4	2020-01-31	C162847	48780-1	9d75b9d0-641e-f424-e053-dadaa90a57ce	70025263 Diethylpropion HCl USP C-IV Immediate-Release 25 mg Tablets Diethylpropion HCl USP C-IV Controlled-Release 75 mg Tablets Rx only Rev. March 2014

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-0121-0	Diethylpropion HCl Controlled-Release	30 in 1 BOTTLE	TABLET	30	12
50090-0121-1	Diethylpropion HCl Controlled-Release	15 in 1 BOTTLE	TABLET	15	12
50090-0121-4	Diethylpropion HCl Controlled-Release	7 in 1 BOTTLE	TABLET	7	12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0121-0	EA - Each	50090-0121	41634ef4-5ae9-4aa1-b169-9cea3d20f8e5	1	2019-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DIETHYLPROPION HYDROCHLORIDE	ACTIVE INGREDIENT	19V2PL39NG	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
DIETHYLPROPION	ACTIVE MOIETY	Q94YYU22B8	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED)	INACTIVE INGREDIENT	Z135WT9208	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1
ZINC STEARATE	INACTIVE INGREDIENT	H92E6QA4FV	DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-0121	DIETHYLPROPION HCL CONTROLLED-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET DIETHYLPROPION HCL IMMEDIATE-RELEASE (DIETHYLPROPION HYDROCHLORIDE) TABLET [A-S MEDICATION SOLUTIONS]	12	Legacy NDC, 3 package rows	20181010_6c57f874-73b4-4769-8947-0b0b3c5dac1d.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
19V2PL39NG	DIETHYLPROPION HYDROCHLORIDE	134-80-5	DIETHYLPROPION HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
978654	diethylpropion HCl 25 MG Oral Tablet	PSN	6c57f874-73b4-4769-8947-0b0b3c5dac1d	12
978668	diethylpropion HCl 75 MG 24HR Extended Release Oral Tablet	PSN	6c57f874-73b4-4769-8947-0b0b3c5dac1d	12
978668	24 HR diethylpropion hydrochloride 75 MG Extended Release Oral Tablet	SCD	6c57f874-73b4-4769-8947-0b0b3c5dac1d	12
978654	diethylpropion hydrochloride 25 MG Oral Tablet	SCD	6c57f874-73b4-4769-8947-0b0b3c5dac1d	12
978668	diethylpropion hydrochloride 75 MG 24 HR Extended Release Oral Tablet	SY	6c57f874-73b4-4769-8947-0b0b3c5dac1d	12

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
50090-0121-0	50090012100	30 in 1 BOTTLE	Historical
50090-0121-1	50090012101	15 in 1 BOTTLE	Historical
50090-0121-4	50090012104	7 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Diethylpropion HCl Controlled-Release	A-S Medication Solutions	2018-10-09	HUMAN PRESCRIPTION DRUG LABEL	12